LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

An epigenetic modifier triggers therapeutic immune responses against breast cancer

Photo from wikipedia

Lorenzo Galluzzi and Guido Kroemer Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA; Universit e Paris Descartes/Paris V, Sorbonne Paris Cit e, Paris, France; Universit e… Click to show full abstract

Lorenzo Galluzzi and Guido Kroemer Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA; Universit e Paris Descartes/Paris V, Sorbonne Paris Cit e, Paris, France; Universit e Pierre et Marie Curie/Paris VI, Paris, France; Equipe 11 labellis ee par la Ligue contre le Cancer, Centre de Recherche des Cordeliers, Paris, France; INSERM, U1138, Paris, France; Metabolomics and Cell Biology Platforms, Gustave Roussy Comprehensive Cancer Institute, Villejuif, France; Pôle de Biologie, Hopitâl Europ een George Pompidou, AP-HP, Paris, France; Department of Women’s and Children’s Health, Karolinska University Hospital, Stockholm, Sweden

Keywords: modifier triggers; epigenetic modifier; paris france; cancer; france

Journal Title: OncoImmunology
Year Published: 2017

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.